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Raccoon rabies, present in the southeastern
United States since the 1950s, became respon-
sible for an epizootic in the U.S. mid-Atlantic
region during the 1970s after raccoons were
translocated there for hunting (1). The
introduction of the variant of rabies virus
associated with raccoons into a rabies-naive
raccoon population caused the most intensive
animal rabies outbreak on record, in part because
of the abundance of raccoons in suburban
environments throughout the mid-Atlantic and
northeastern metropolitan areas. Raccoon rabies
affects approximately one million square
kilometers of the eastern United States with a
human population of approximately 90 million.
Since the mid-Atlantic raccoon rabies
epizootic entered New York State in 1990, the
number of rabid animals increased from 54 in
pre-epizootic 1989 to 2,746 (89% raccoons) in
1993the largest number of rabid animals ever
reported from any state (2). Despite traditional
public health measures for rabies control (e.g.,
pet vaccination, stray animal control, public
education), human rabies postexposure prophy-
laxis (PEP) rates inevitably increased with the
arrival of the epizootic front (3). Preliminary
data from New York documented a 4,000%
increase in the absolute number of persons
receiving PEP, from 81 (1989) to 3,336 (1993) (4).
The epidemiologic trends of human PEP in New
York State remain largely undescribed.
One of the Healthy People 2000 objectives
formulated by the U.S. Public Health Service is
to reduce by 50% the need for human rabies PEP
by the year 2000 (5). A reduction in the number of
PEP cases, which are not reportable, appears
unattainable without first defining the numera-
tor, as well as the epidemiologic characteristics
of precipitating events leading to suspected
rabies exposure and inappropriate treatments.
We describe demographic and animal
exposure data associated with human rabies
PEP in an area with epizootic raccoon rabies. The
epidemiologic description is intended to assist
medical practitioners and public health officials
in reducing the incidence of human and domestic
animal exposure to rabid animals and thus in
minimizing the need for PEP in communities
affected by the raccoon rabies epizootic.
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We describe the epidemiology of human rabies postexposure prophylaxis (PEP) in
four upstate New York counties during the 1st and 2nd year of a raccoon rabies
epizootic. We obtained data from records of 1,173 persons whose rabies PEP was
reported to local health departments in 1993 and 1994. Mean annual PEP incidence
rates were highest in rural counties, in summer, and in patients 10 to 14 and 35 to 44
years of age. PEP given after bites was primarily associated with unvaccinated dogs
and cats, but most (70%) was not attributable to bites. Although pet vaccination and
stray animal control, which target direct exposure, remain the cornerstones of human
rabies prevention, the risk for rabies by the nonbite route (e.g., raccoon saliva on pet
dogs’ and cats’ fur) should also be considered.416 Emerging Infectious Diseases Vol. 5, No. 3, MayJune 1999
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Figure 1. New York State raccoon rabies epizootic
progression (1990-94). The raccoon rabies epizootic
first affected Monroe, Wayne, Cayuga, and Onondaga
Counties between December 1992 and June 1993.
The Study
Setting
Four contiguous upstate New York counties
(Monroe, Wayne, Cayuga, and Onondaga) were
first affected by the raccoon rabies epizootic
between December 1992 and June 1993 (Figure
1). Monroe and Onondaga Counties, encompass-
ing the cities of Rochester and Syracuse, are
predominantly urban-suburban, with human
population densities of 414 per square kilometer
and 230 per square kilometer, respectively.
Wayne and Cayuga Counties are predominantly
rural-suburban, with relatively lower population
densities of 57 and 45 people per square
kilometer, respectively. The four-county region
in western upstate New York comprises 7,090
square kilometers and has an estimated human
population of 1,354,377.
Data Characteristics and Sources
We considered all human rabies PEP cases
reported in 1993 and 1994 for the study area. The
PEP capture rate was believed high because local
health units were responsible for providing
funds for any treatment expenses not covered by
health insurance, and a completed, rabies report
form was required before reimbursement of the
local health unit from state funds.
The New York State Sanitary Code requires
physicians to report potential human exposure to
rabies and PEP administration to county health
departments. We abstracted data from these
standardized reports and patient records. Data
were grouped by patient demographics, animal
characteristics, and exposure details. Exposure
source was defined as the suspected- or
confirmed-rabid animal that directly or indi-
rectly resulted in one or more potential human
exposures to rabies. Direct contact exposure
consisted of direct contact (e.g., bite, scratch) or
contamination of mucous membranes with
potentially infectious material from a rabid
animal. Indirect contact consisted of contamina-
tion from a fomite (e.g., through racoon saliva on
a pets fur with a pet owners open wounds or
mucous membranes).
Analyses
Population figures from the 1990 New York
State census were used to calculate the incidence
of PEP by county, age, and gender (6).
Descriptive analyses of data elements were made
through queries of Microsoft Access relational
database. Each PEP contributed to the
denominator of the analyses. Since multiple PEP
cases occurred from exposure to a single animal,
data for individual animals were also summa-
rized. Chi-square tests were performed with Epi-
Info Version 5 software.
Findings
PEP Incidence
The annual PEP incidence for the study area
increased from <1 case per 100,000 residents in
pre-epizootic 1992 to 35 cases in 1993 and 52
cases in 1994. Of 1,173 cases of human rabies
PEP in the study areas, 474 were reported in
1993 and 699 cases were reported in 1994. The
mean annual incidence of PEP was 32 cases per
100,000 for the urban counties (Monroe and
Onondaga; 315 residents per square kilometer)
and 123 cases per 100,000 for the two rural
counties (Wayne and Cayuga; 51 residents per
square kilometer).
Season
The number of PEP cases peaked in summer
to early autumn (Figure 2). During 1993, the
highest number of PEP cases occurred approxi-
mately 4 to 6 months (August through November)
after the invasion of raccoon rabies during March
through June 1993; in 1994, the highest number
occurred in summer (June through August).417 Vol. 5, No. 3, MayJune 1999 Emerging Infectious Diseases
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Figure 2. Human rabies postexposure prophylaxis in four New York State counties
(Cayuga, Monroe, Onondaga, and Wayne), 1993-1994, by month.
Figure 3. Human rabies postexposure prophylaxis in four New York State counties
(Cayuga, Monroe, Onondaga, and Wayne), 1993-94: incidence by gender and age.
Gender and Age
Gender and age data were available for 100%
and 95% of all patients, respectively. Of 1,173
PEP cases, 642 (55%) were administered to male
and 531 (45%) to female patients. The mean
annual incidence of PEP in male and female
patients was 47 and 38 per 100,000, respectively.
The PEP rates were highest in persons 10 to 14
years of age (165 per 100,000) and 35 to 44 years
of age (113 per 100,000) (Figure 3). The median
age was 29 and 31 years for male and female
patients, respectively. No significant relation-
ship was observed
between gender and
age groups for the
study area.
Exposure Source
Species
Exposure to wild
animals accounted
for 783 (67%) of all
PEP cases (Table
1). Among wildlife,
raccoons were by
far the leading
source of exposure,
accounting for 589
(75%) of 779 PEP
cases due to wild-
life exposure. The
other sources of wildlife exposure were bats (54
cases), skunks (35 cases), foxes (28 cases), white-
tailed deer (13 cases), woodchucks (12 cases),
small rodents (9 cases), sika deer (4 cases), and
other wild species (39 cases). Of 390 domestic
animal exposures resulting in PEP, 205 were
attributed to cats, 165 to dogs, 12 to cattle, 5 to
pet rabbits, and 3 to horses. Among PEP cases
resulting from exposure to cats and dogs, 66%
and 67%, respectively, were initiated after
contact with stray animals unavailable for the
recommended 10-day confinement and observa-
tion to rule out
rabies or euthana-
sia and testing. Dog
exposures were dis-
proportionately
higher in urban (137
[18%] of 753) than
in rural counties (28
[7%] of 420)
(p <0.001) (Table 2).
In urban areas, dog
exposure was pri-
marily due to stray
or unowned dogs
(95 [69%] of 137). In
rural areas, stray or
unowned dogs ac-
counted for 11 (39%)
of 28 dog exposures
(p <0.01). Only one
dog (in a rural
county) tested posi-418 Emerging Infectious Diseases Vol. 5, No. 3, MayJune 1999
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Table 1.  Human rabies postexposure prophylaxis (PEP), New York State, 1993-94a
Nonbite (N=818) Overall
    Bite Directb Indirectc   total
 (N=355) Scratch   Saliva    NT  Blood   Saliva       PEP
Animal source   N ( %)  N (%)   N ( %)  N (%)  N (%)   N (%)      N (%)
Raccoon   37 (10) 18 (33)   44 (29) 4  (67) 13   (93) 472d (79)    589e  (50)
Bat (all species)   29   (8)   3   (6)   12   (8) 1  (17)   0     (0)     9    (2)      54    (5)
Other wild species   24   (7)   5 (11)   21 (14) 0    (0)   1     (7)   89  (15)    140  (12)
All wild species   90 (25) 26 (47)   77 (51) 5  (84) 14 (100) 570  (96)    783  (67)
Cat 114 (32) 29 (53)   41 (28) 0    (0)   0     (0)   21    (4)    205  (17)
Dog 151 (43)   0   (0)   13   (9) 0    (0)   0     (0)     1  (<1)    165  (14)
Other domestic species     0   (0)   0   (0)   19 (13) 1  (17)   0     (0)     0    (0)      20    (2)
All domestic species 265 (75) 29 (53)   73 (49) 1  (17)   0     (0)   22    (4)    390   (33)
Total 355 (30) 55 (55) 150 (13) 6 (0.5) 14 (1) 592   (51) 1,173 (100)
aData are from Cayuga, Monroe, Onondaga, and Wayne Counties.
bDirect contamination of an open wound or mucous membrane with potentially infectious material such as saliva, nervous tissue
(NT), or blood (mixed with other body fluids), from a rabies-suspect or known-rabid animal.
cNo direct contact with a rabid or suspect-rabid animal. Indirect exposure through possible conveyance of saliva on an animal
(i.e., pet dog or cat) or inanimate object resulting in contamination of an open wound or mucous membrane.
dp < 0.001. More people received PEP after indirect exposure to saliva from raccoons than from any other species (472 PEP cases
due to indirect contact with 261 raccoons).
eTotal PEP cases with raccoon as an exposure source (includes one case with no reported route of exposure).
Table 2. Human rabies postexposure prophylaxis (PEP)
in New York State, 1993-94: urban and rural settingsa
All four
Animal Urban Rural counties
source N (%) N (%) N (%)
Dogb 137  (18)   28   (7)       165 (14)
Cat 130  (17)   75 (18)       205 (17)
Other domestic     5 (<1)   15   (4)         20   (2)
  speciesc
All domestic 272  (35) 118 (28)       390 (33)
  species
Raccoon 341  (45) 248 (59)       589 (50)
Bat (all species)   41    (5)   13   (1)         54   (5)
Striped skunk   29    (4)     6 (<1)         35   (3)
Fox 19 (3)     9    (2)   28   (2)
Other wild   51    (4)   26   (2)         77   (7)
  speciesd
All wild species 481  (65) 302 (72)       783 (67)
Total 753 420 1,173
Rate per   32 123      43
  100,000 pop.
aCharacteristics of human rabies PEP cases reported to the
health departments of the two relatively urbanized counties,
Onondaga and Monroe, and the two relatively rural counties
Cayuga and Wayne, during 1993 and 1994.
bp < 0.00. Human PEP rates due to dog exposures were
significantly higher in urban counties.
cOther domestic species include 2 and 3 PEP cases due to cow
and horse exposure in the urban counties and 10 and 5 cases
due to cow and domestic rabbit exposure in the rural counties,
respectively.
dOther wild species includes 17, 6, 4, 2, 2, and 1 PEP  cases due
to an unknown animal type, wild rodent (other than
woodchuck), 4 Sika deer (exotic, captive species), opossum,
coyote, and mink in the urban counties and 17 and 3 PEP
cases due to an unknown animal type and wild rodent (other
than woodchuck) in the rural counties, respectively.
tive for rabies in the study area in 1993 and 1994.
Of 68 pet cats resulting in human exposure, 61
(90%) were not vaccinated against rabies
compared with 14 (24%) of 58 pet dogs (p <0.001).
Type of Exposure
Of 1,173 PEP cases, 355 (30%) resulted from
animal bites and 817 (70%) from nonbite
encounters (Table 1). A route of exposure not
reported in one case involved a raccoon.
Suspected contact with animal saliva (148 cases
from direct contact and 594 from indirect
contact) was responsible for 742 (91%) of 817 PEP
cases due to nonbite exposure; contact with
nervous tissue (6 PEP cases) or blood (14 PEP
cases) accounted for 2% of cases due to nonbite
exposure. Fifty-five (7%) of 817 nonbite
exposures were attributable to scratches from 23
cats (responsible for 29 PEP cases), 16 raccoons
(18 cases), 3 bats (3 cases), 2 wild rodents (2
cases), and 3 other wild animals (3 cases). Of 355
bite exposures, 265 (75%) involved domestic
animals (151 due to 150 dogs, 114 due to 108
cats); 90 (25%) involved bites from wild
animals34 raccoons (responsible for 37 PEP
cases), 27 bats (29 cases), 9 rodents (9 cases), and
13 other wild species (15 cases).
Mode of Contact
Of 1,173 cases, 594 (51%) occurred because of
possible indirect contact with a suspect rabid419 Vol. 5, No. 3, MayJune 1999 Emerging Infectious Diseases
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Table 3.  Human rabies postexposure prophylaxis (PEP) in New York State, 1993-94: Epidemiologic characteristicsa
Group size
1 2 34 56 +
Characteristic N  % N  % N  % N  % N    % N  %
Number 625 53 180 15 84   7 112 10 60     5 112 10
No. of sources 625 79   90 11 28   4   28   4 12     2   13   2
Route of exposure
  Biteb 328 52   17   9   4   5     3   3   0     0     3   3
  Nonbite 296 47 163 91 80 95 109 97 60 100 109 97
  Unknown     1   0.2     0   0   0   0     0   0   0     0     0   0
Source of exposure
  Dog or cat 273 44   16   9   3   4     4   4 10   17   64 57
  Other domestic species     2   0.3     4   2   3   4     4   4   5     8     6   5
  Raccoon 235 38 124 69 57 68   96 86 35   58   42 38
  Bat   39   6   12   7   3   4     0   0   0     0     0   0
  Other wild species   76 12   24 13 18 21     8   7 10   17     0   0
Mean age (yr)   33.4   32.5 24.8   22.5 21.8 26.0
aPEP data are from Cayuga, Monroe, Onondaga, and Wayne Counties.
bProbability of bite exposure for PEP involving single person vs. group of  >1 PEP cases, p <0.001.
animal; 583 (98%) of 594 occurred after
suspected exposure to saliva from a rabid (or
suspect rabid) animal on the fur of a nonsuspect
dog, cat, or other animal. In 9 (2%) of these cases,
PEP was administered after suspected exposure
by possibly contaminated fomites including door
knobs, traps, arrows, a flashlight, and a wire.
Possible indirect exposure to dogs with
potentially infectious material on their fur
resulted in 507 (85%) PEP cases, while suspected
indirect exposure by cats resulted in 70 (12%)
cases. Other suspected exposure sources were a
horse, rabbit, pet duck, chicken, wild bird,
captive exotic sika deer, and a person.
Group Exposure
Exposure of one person to a suspect rabid
animal precipitated 625 (53%) PEP cases; the
remaining 548 (47%) occurred after more than
one person was exposed to the same suspected
animal (Table 3). Exposure of a single person was
more likely associated with a bite (p <0.001),
while group exposure (involving two or more
persons) was more likely associated with
nonbites (p <0.001). Wild animal species
accounted for most group exposureswith three
exceptions. The largest group exposures (involv-
ing 12, 13, and 14 people) were associated with
the handling of rabid domestic animals (before
diagnosis) by veterinary clinic employees.
Rabies Status
The laboratory diagnosis of rabies in the
exposing animal was associated with 540 (46%)
of all PEP cases (445 due to wildlife and 95 due to
domestic animals). Eighty-nine percent of PEP
cases attributed to rabid wildlife involved
raccoons. In 88 cases, PEP was initiated after
contact with animals eventually proven nonrabid.
In 544 cases PEP was administered after contact
with animals not tested for rabies. Confirmation
of rabies in suspect domestic animals occurred in
association with 91 (23%) of 390 PEP cases
resulting from exposure to domestic species,
including 40 due to 5 pet cats, 23 to 5 stray cats,
13 to 1 pet dog, 5 to a domestic rabbit, 7 to a cow,
and 3 to a horse. Conversely, in 88 (8%) of all
cases PEP was given after encounters with 81
animals subsequently proven nonrabid (35 due
to 33 cats, 32 to 32 dogs, 9 to 8 raccoons, 3 to 3
bats, 5 to 2 skunks, 1 to 1 woodchuck, 1 to 1
squirrel, and 2 to 1 muskrat).
Of 540 cases of PEP associated with animals
proven to be rabid, 505 (94%) were due to
suspected saliva exposure; 22 (4%) and 13 (2%)
involved bites or scratches, respectively. Con-
versely, 71 (81%) of 88 PEP cases associated with
nonrabid animals (i.e., laboratory-confirmed as
negative or confined and observed to be healthy)
occurred after bite exposures. Of the 544 PEP
cases associated with animals of unknown rabies
status, 48% were due to bites, 45% to suspected
saliva contacts, and 7% to scratches.
Wild animals accounted for 98% of the 690
animals submitted and testing positive for rabies
in the study area for 1993-94; 613 were raccoons.
If animals testing positive for rabies are used as
a surrogate for the true incidence, an420 Emerging Infectious Diseases Vol. 5, No. 3, MayJune 1999
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approximately 20-fold increase in PEP cases per
rabid domestic animal compared with each rabid
wild animal, regardless of rural or urban region,
is seen (data not shown).
Provoked Exposures
A provoked exposure was characterized by
intentional, human-initiated interaction with a
suspect rabid animal. Cases resulting from
provoked exposure accounted for 392 (33%) of
1,173 of all PEP cases; 248 (63%) involved
domestic animals. Most cases resulting from
provoked exposure of domestic animals involved
cats (162 [65%] of 248) and less frequently, dogs
(62 [25%] of 248). Wild animals accounted for 144
(37%) PEP cases from provoked exposure.
Time of PEP Initiation
The interval between exposure to suspect
rabid animals and initiation of PEP was 0 to 43
days (median 2 days). Bite exposures were
associated with no delay in treatment; nonbite
exposures were associated with a 3- to 4-day
interval (p <0.001).
PEP Regimen
In 1993 and 1994, postexposure biologic
products licensed for use in the United States
were rabies vaccine adsorbed, human diploid cell
vaccine (Imovax), and human rabies immune
globulin (HRIG; Hyperab or Imogam). As
recommended by the Advisory Committee on
Immunization Practices (ACIP), PEP for the
rabies-naive person consists of HRIG (20 IU/kg)
on day 0 and five doses of rabies vaccine
administered on days 0, 3, 7, 14, and 28 (7).
Scheduling information was unavailable for our
cases.
Administration of PEP biologic products was
recorded as complete in 1,016 (87%) of 1,173 PEP
cases. Information regarding completion of the
treatment series was not available in 15 cases
(1%). Appropriate PEP for preimmunized
persons consists of two vaccine doses on days 0
and 3 (7) and was administered to 26 persons,
accounting for 2% of all cases. Among
preimmunized persons, 17 (65%) of 26 PEP cases
occurred after occupational exposures by 11
veterinary staff personnel (including two group
exposures to proven rabid cats), four wildlife
rehabilitators, one health department employee,
and one police officer.
In 54 (5%) instances, PEP was discontinued
because of lack of clinical signs in 29 dogs (29
PEP cases) and 23 cats (25 PEP cases) confined
for the recommended 10-day observation period.
Moreover, 34 (3%) PEP cases were discontinued
because of rabies-negative laboratory results in
10 cats (10 PEP cases), 7 raccoons (8 cases), 2
skunks (5 cases), 4 dogs (4 cases), 3 bats (3 cases),
1 muskrat (2 cases), 1 woodchuck (1 case), and 1
squirrel (1 case).
After PEP was initiated, 29 (2%) of 1,173
refused to complete the series; two cited adverse
reactions. In nine cases PEP deviated from ACIP
recommendations: apparently inadvertent sched-
uling and administration of six total vaccine
doses in four patients and intentional omission of
HRIG in the treatment regimen of five patients.
Adverse Effects
The categories available for characterizing
adverse effects on the state rabies report form
were none, slight, moderate, severe, or
unknown. In 596 (51%) of 1,173 PEP cases, no
information was recorded. Of 577 responses, 495
(86%) reported no adverse effects resulting from
PEP. Adverse effects were characterized as
slight by 67 (12%) persons. Moderate adverse
reactions including vomiting, nausea, fever,
aches, and weakness were reported by 13 (2%)
persons. Serious systemic adverse reactions,
recorded as anaphylactic shock and serum
sickness, occurred in two (0.2%) persons. Both of
these patients had received HRIG; PEP was
discontinued after one and two vaccine doses in
each case.
Conclusions
The most important finding of this study was
that in most cases PEP was administered
because of suspected nonbite, indirect exposure
to animal saliva, a route conventionally thought
of nearly negligible risk in rabies transmission
(7,8). Because of effective PEP, public health
personnel and health-care workers are primarily
challenged with the assessment of exposure to
rabies, rather than with treatment of human
cases of the disease. Assessment of nonbite saliva
exposures are particularly time-consuming and
should consist of a thorough, but nonleading,
history-taking that elicits the probability or
confirmation of mucous membrane or nonintact
skin contact and a realistic assessment of the421 Vol. 5, No. 3, MayJune 1999 Emerging Infectious Diseases
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potential presence of infectious saliva on
surfaces or pets. Given the invariably fatal
outcome of clinical rabies, the tendency may be to
administer PEP, even without clear indication of
exposure. This tendency may be unwisenot
only for economic reasons, but also because,
despite their relative innocuity and high
potency, modern rabies biologic products, are not
risk-free, nor is their supply unlimited.
The first descriptive study of PEP cases
associated with the mid-Atlantic raccoon rabies
epizootic during 1982-83 (133 patients) also
documented that most PEP cases were due to
nonbite exposures; however, these principally
involved direct exposure to the suspect rabid
animal (1).
A 1980-81 nationwide survey of 5,634 PEP
cases found an increased risk for occupational
and recreational exposure to animals in a rural
setting (9). The absolute mean annual PEP rate
described in our report of 43 per 100,000 was
nearly 10-fold higher than the rate of 4.7 per
100,000 reported in that study. A rate of 66 per
100,000 was reported from two counties (93
people per square kilometer) in New Jersey at
the raccoon rabies epizootic front in 1990 (10,11).
The incidence of human rabies PEP in New
Jersey and this study exceeded by 10- to 20-fold
the rates in areas reporting rabies in skunks
(12,13), raccoons (14), and mixed wildlife (9,15).
The disparity may be partially explained by
regional epizootic versus enzootic status of
wildlife rabies and subsequent variations in the
comparative intensity of disease in wildlife
populations, as well as recent increases in both
human and animal population densities and
their close association in suburban settings (2).
The previous PEP studies involved communities
in which rabies had been enzootic in terrestrial
wildlife for decades (9,12-16). However, the mid-
Atlantic raccoon rabies epizootic comprises the
emergence of a terrestrial rabies variant into
areas that had, for the most part, been free of
terrestrial rabies. The exceptions were sporadic
cases of spillover from geographically wide-
spread, but low-level, bat rabies into terrestrial
animals and occasional incursions of red fox
rabies from Canada into New York, Vermont,
and other northern states (2,16).
Previous studies of PEP trends in the United
States identified bites from dogs and cats as the
most common animal encounter, accounting for
65% to 84% of PEP cases (7,9,12-15). By contrast,
only 23% of PEP cases in this study were
associated with dog or cat bites. In view of
current epidemiologic trends in canine rabies-
free areas of the United States, if a biting dog
appears clinically normal and can be confined
and observed for signs of rabies, the decision to
administer PEP may be based on suggestive
clinical signs and a prompt diagnostic evaluation
that confirms rabies rather than on presump-
tively initiating PEP. Given that cats are now the
leading rabid domestic animal in the United
States (17), and more specifically that 12 of the
13 domestic species confirmed rabid from the
four-county study area during 1993 and 1994
were cats, rabies vaccinations for cats should
become more prevalent. Among exposures to
owned domestic pets that resulted in human
PEP, 9% of cats (versus 76% of dogs) were
vaccinated against rabies. Moreover, most of the
encounters with dogs that precipitated PEP in
urban counties involved bites from stray dogs,
indicating the need for enhanced programs for
urban dog control.
The economic impact of a new terrestrial
rabies variant is substantial (2,18). In 1994, the
New York State Department of Health increased
its reimbursement to local health units for
mandated rabies control activities from $75,000
to $1,080,000 to assist in the expense associated
with human rabies PEP, animal rabies testing
(11,896 specimens in 1993), and pet immuniza-
tion clinics (114 in 1993) (4). Local health units in
New York State provide funds for treatment
expenses not covered by health insurance. With
the cost of rabies biologic products alone
exceeding $1,500 per treatment series, an
exponential increase in the incidence of PEP, as
documented in this study, taxes the public health
infrastructure. Moreover, unlike red fox rabies,
which periodically reinvades northeastern New
York from adjoining areas of Canada and
Vermont but then dies out, raccoon rabies is
expected to persist in affected areas of New York
State, as it has in the southeastern United States
for the past 5 decades and in the mid-Atlantic
and northeastern states more recently (17).
Control of canine rabies in the United States
and other industrialized countries was achieved
by eliminating the susceptible reservoir popula-
tion (through stray dog control and mandatory
vaccination) (16). Applications of this concept to422 Emerging Infectious Diseases Vol. 5, No. 3, MayJune 1999
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wildlife is problematic because of the difficulty in
capturing wild animals for vaccination or for
applying lethal measures. Population reduction
alone is not sufficient to control or eliminate
terrestrial wildlife rabies variants over large
geographic areas (16). An emerging alternative
is oral rabies vaccination of free-ranging
reservoir populations, although current methods
are still in their infancy and the cost-benefit of
such interventions warrants further investiga-
tion (10).
During the enzootic raccoon rabies in the
southeastern states since the early 1950s or the
current mid-Atlantic/northeastern United States
epizootic, this variant has not been known to
cause human rabies deaths. Yet its potential
lethality for humans is supported by ample
spillover into other wild animal species
(predominantly skunks, but also red foxes,
bobcats, and woodchucks) and into domestic
animals (predominantly cats, but also dogs,
cows, horses, goats, and rabbits). Substantial
amounts of infectious rabies virus have been
identified in the salivary glands of rabid raccoons
(19). No biologic or epidemiologic data suggest
unique attenuation or change in virulence of this
particular rabies variant that would account for
a lack of identified human deaths. Instead,
epidemiologic data regarding PEP after sus-
pected exposure to raccoon rabies indicate that
PEP frequently is administered even when no
exposure has been identified. Also, a bite,
scratch, or other exposure, such as gross
contamination of an open wound or mucous
membrane with moist, infectious material from a
small carnivore such as the raccoon, would
unlikely be unrecognized or ignored. The
apparent liberal administration of effective PEP
after known bites, scratches, and other
suspected exposures from rabid raccoons may
have resulted in complete prevention of human
deaths due to this variant of rabies virus
associated with raccoons.
Although the Healthy People 2000 goal to
reduce PEP is worthwhile, better understanding
of the circumstances leading to human exposure
and formulating ways to reduce exposure is
required to meet this objective. Until then, it will
be particularly difficult to reduce PEP during an
ever-expanding raccoon rabies epizootic.
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